Total offers pharma processing and packaging solutions

Published: 21-Apr-2010
Manufacturing

Interphex Hub will stage series of free seminars with top industry speakers

Total Processing & Packaging 2010 takes place at the NEC, Birmingham, UK, from 25 – 27 May. The exhibition will feature for the first time a Robotics & Industrial Vision Pavilion that will showcase the latest technology solutions that enable businesses to increase productivity while also delivering efficiency savings.

Further highlights will be a series of dedicated free-to-attend seminars in both the Packaging Innovation and Interphex hubs.

Top pharmaceutical companies and specialist equipment suppliers have been confirmed as speakers for the Interphex Hub seminars. Leading names taking part in the seminar programme, sponsored by Bürkert Fluid Control Systems and chaired by Mike Warren, formerly of Niro Pharma, include GlaxoSmithKline, R5 Pharmaceuticals, Atacama Labs, Upperton, Oystar Manesty, Cognex, Hapa and Pharma Tech.

Taking place over the three days of the show, topics will include anticounterfeiting and mass serialisation, Track & Trace technologies, 2D data matrix codes, new technologies for formulation development and GMP manufacture, and a new system for the online monitoring of tablet coating thickness.

‘As a strong Reed Exhibitions brand known around the world, Interphex offers the ideal platform for companies to demonstrate their latest solutions to a wide variety of packaging and production challenges,’ said Ian Crawford, Group Exhibition Director. ‘The seminar programme is an excellent focal point for the Hub and promises to deliver some very interesting presentations and stimulating debates.’
See more

You may also like

Manufacturing

Optima Group offers innovative pharma ideas

Read more
Total Processing & Packaging exhibition Stand no: 5181

Trending Articles

  1. FDA issues first cGMP warning letter citing AI misuse in pharmaceutical manufacturing A Michigan-based lab has become the subject of the FDA's first dedicated enforcement action on artificial intelligence misuse in drug manufacturing — a landmark event with far-reaching implications for cGMP compliance across the pharmaceutical supply chain
  2. Japanese pharma companies shifting to earlier CDMO outsourcing as peptide complexity increases Neuland Laboratories has reported a notable shift in Japanese pharmaceutical outsourcing patterns during the past 12-24 months, with companies engaging CDMOs earlier in the development cycle
  3. UK REACH reform falls short as industry warns of £500m+ compliance bill The UK chemicals industry has condemned the Government's long-awaited response to the UK REACH Alternative Transitional Registration model consultation, arguing it does little to support growth or innovation
  4. Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
  5. Dr. Simon Bulling joins ProBioGen as Chief Operating Officer to drive next phase of operational growth ProBioGen announced the appointment of Dr. Simon Johannes Bulling, PhD, as Chief Operating Officer (COO), effective April 15, 2026

Upcoming event

CHEMUK 2026

20–21 May 2026 | Conference and Exhibition | Birmingham, UK See all

You may also like

Manufacturing

Optima Group offers innovative pharma ideas

<b>Total Processing & Packaging exhibition<br> <i>Stand no: 5181</i></b>
Manufacturing

Almac highlights SDS-PAGE approach for residual protein determination in new white paper

New white paper explores robust analytical method for residual protein detection in biocatalytic API manufacturing
Manufacturing

Reliable, high-performance pump for HPLC and UHPLC

Biotech Fluidics announce the ASI 540 – an affordable, standalone solvent delivery pump - design optimised for liquid chromatography applications
Manufacturing

BD and Suttons Creek collaborate to streamline combination product development for pharma and biotech

The new strategic collaboration will help pharmaceutical and biotech companies reduce development risk and regulatory complexity across drug-device combination products, including biologics and GLP-1 therapies
Manufacturing

Miltenyi Biotec and CHA Biotech collaborate on BaEV lentiviral vector platform

The pair will work to enhance CAR NK cell therapy manufacturing efficiency, combining Miltenyi Bioindustry's baboon envelope lentiviral vector platform with CHA Biotech's NK cell research expertise to improve gene delivery, scalability and cost of goods
Manufacturing

Piramal Pharma Solutions and Ajinomoto Bio-Pharma Services collaborate to support ADC development and manufacturing

Piramal and Ajinomoto Bio-Pharma Services have entered a collaborative arrangement aimed at enhancing their customers’ ADC development and manufacturing programs
Manufacturing

Cipla receives FDA approval for first AB-rated generic of Ventolin HFA in $1.5bn US albuterol market

Indian pharmaceutical company Cipla has secured final FDA approval for its Albuterol Sulfate Inhalation Aerosol, becoming the first AB-rated generic therapeutic equivalent of GlaxoSmithKline's Ventolin HFA
Subscribe now